|
|
Article: Essential Therapeutics Announces Receipt of Nasdaq Staff Determination Letter.
- Article from:
- PR Newswire
- Article date:
- January 31, 2003
CopyrightCOPYRIGHT 2003 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Essential Therapeutics, Inc. today announced the receipt of a Nasdaq Staff determination letter indicating that the Company's securities will be delisted from the Nasdaq National Market at the opening of business on February 10, 2003 due to the Company's failure to comply with the Nasdaq National Market System listing criteria which require the Company to maintain a minimum stockholders' equity of $10 million. The Company has the right to appeal the Staff's determination to the Nasdaq Listing Qualifications Panel, and the hearing request will stay the delisting of the Company's securities pending the Panel's decision. The Company intends to request such a hearing.
...
Related newspaper, magazine, and journal articles:
|
|
Article: Essential Therapeutics to Develop Reorganization ...
PR Newswire;
April 22, 2003 ;
604 words
...Essential Therapeutics, Inc. (BULLETIN BOARD: ETRX ... holders of its Series B Convertible Preferred Stock to jointly develop a plan of reorganization ... risks and uncertainties affecting Essential Therapeutics' business, see the Company ...
|
|